Present and future innovations in AI and cardiac MRI

MA Morales, WJ Manning, R Nezafat - Radiology, 2024 - pubs.rsna.org
Cardiac MRI is used to diagnose and treat patients with a multitude of cardiovascular
diseases. Despite the growth of clinical cardiac MRI, complicated image prescriptions and …

Artificial intelligence in cardiovascular medicine: clinical applications

TF Lüscher, FA Wenzl, F D'Ascenzo… - European heart …, 2024 - academic.oup.com
Clinical medicine requires the integration of various forms of patient data including
demographics, symptom characteristics, electrocardiogram findings, laboratory values …

Microstructural and microvascular phenotype of sarcomere mutation carriers and overt hypertrophic cardiomyopathy

G Joy, CI Kelly, M Webber, I Pierce, I Teh, L McGrath… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: In hypertrophic cardiomyopathy (HCM), myocyte disarray and
microvascular disease (MVD) have been implicated in adverse events, and recent evidence …

Genetic architecture of cardiac dynamic flow volumes

B Gomes, A Singh, JW O'Sullivan, TM Schnurr… - Nature Genetics, 2024 - nature.com
Cardiac blood flow is a critical determinant of human health. However, the definition of its
genetic architecture is limited by the technical challenge of capturing dynamic flow volumes …

Clinician's guide to trustworthy and responsible artificial intelligence in cardiovascular imaging

L Szabo, Z Raisi-Estabragh, A Salih… - Frontiers in …, 2022 - frontiersin.org
A growing number of artificial intelligence (AI)-based systems are being proposed and
developed in cardiology, driven by the increasing need to deal with the vast amount of …

Avdnet: Joint coronary artery and vein segmentation with topological consistency

W Wang, Q Xia, Z Yan, Z Hu, Y Chen, W Zheng… - Medical Image …, 2024 - Elsevier
Coronary CT angiography (CCTA) is an effective and non-invasive method for coronary
artery disease diagnosis. Extracting an accurate coronary artery tree from CCTA image is …

Apical ischemia is a universal feature of apical hypertrophic cardiomyopathy

RK Hughes, JB Augusto, K Knott, R Davies… - Circulation …, 2023 - Am Heart Assoc
Background: Apical hypertrophic cardiomyopathy (ApHCM) accounts for≈ 10% of
hypertrophic cardiomyopathy cases and is characterized by apical hypertrophy, apical cavity …

Improved diagnostic criteria for apical hypertrophic cardiomyopathy

RK Hughes, H Shiwani, S Rosmini, JB Augusto… - Cardiovascular …, 2024 - jacc.org
Background There is no acceptable maximum wall thickness (MWT) threshold for
diagnosing apical hypertrophic cardiomyopathy (ApHCM), with guidelines referring to≥ 15 …

Cardiac aging synthesis from cross-sectional data with conditional generative adversarial networks

VM Campello, T Xia, X Liu, P Sanchez… - Frontiers in …, 2022 - frontiersin.org
Age has important implications for health, and understanding how age manifests in the
human body is the first step for a potential intervention. This becomes especially important …

Machine learning approaches in diagnosis, prognosis and treatment selection of cardiac amyloidosis

A Allegra, G Mirabile, A Tonacci, S Genovese… - International Journal of …, 2023 - mdpi.com
Cardiac amyloidosis is an uncommon restrictive cardiomyopathy featuring an unregulated
amyloid protein deposition that impairs organic function. Early cardiac amyloidosis …